The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery-Reference-Cited by-同舟云学术

The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery

Published:2019-07-18 Issue:10 Volume:14 Page:1037-1052
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Du Yu¹,Li Xingxing¹²,Su Chunyan¹,Wang Li¹,Jiang Jiandong¹,Hong Bin¹²

Affiliation:

1. NHC Key Laboratory of Biotechnology of Antibiotics, Beijing, China

2. CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Beijing Municipality

CAMS Innovation Fund for Medical Sciences

Drug Innovation Major Project

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1638909

Reference169 articles.

1. The Burden of Disease and the Changing Task of Medicine

2. How can high-throughput screening deliver drugs to treat atherosclerosis?

3. High-density lipoprotein-based drug discovery for treatment of atherosclerosis

4. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosynthetic gene clusters of symbiotic gut microbiome in succession of human health;Microbial Symbionts;2023

2. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-12

3. Coronary heart disease and gut microbiota: A bibliometric and visual analysis from 2002 to 2022;Frontiers in Cardiovascular Medicine;2022-09-08

4. Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases;Foods;2022-08-25

5. Gut microbiota and metabolic changes towards improved gut health with supplementation of Woodfordia fruticosa, a medicinal plant: An in vitro study;Innovative Food Science & Emerging Technologies;2022-01